Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
93.86
+1.06 (1.14%)
At close: Apr 28, 2026, 4:00 PM EDT
93.90
+0.04 (0.04%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Abbott Laboratories Stock Forecast

Stock Price Forecast

The 20 analysts with 12-month price forecasts for Abbott Laboratories stock have an average target of 130.9, with a low estimate of 115 and a high estimate of 148. The average target predicts an increase of 39.46% from the current stock price of 93.86.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $115 $130.9 $131 $148
Change +22.52% +39.46% +39.57% +57.68%

Analyst Ratings

The average analyst rating for Abbott Laboratories stock from 20 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 9999710
Buy 778888
Hold 222222
Sell 000000
Strong Sell 000000
Total 181819191720

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
BTIG
BTIG
Strong Buy
Reiterates
$131
Strong Buy Reiterates $131 +39.57% Apr 27, 2026
Barclays
Barclays
Buy
Maintains
$144$143
Buy Maintains $144$143 +52.35% Apr 20, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$135$115
Buy Maintains $135$115 +22.52% Apr 17, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$132$115
Buy Maintains $132$115 +22.52% Apr 17, 2026
RBC Capital
RBC Capital
Buy
Maintains
$135$130
Buy Maintains $135$130 +38.50% Apr 17, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
49.09B
from 44.33B
Increased by 10.75%
Revenue Next Year
53.07B
from 49.09B
Increased by 8.10%
EPS This Year
5.70
from 3.72
Increased by 53.29%
EPS Next Year
6.28
from 5.70
Increased by 10.19%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
43.08B43.65B40.11B41.95B44.33B49.09B53.07B
Revenue Growth
24.47%1.34%-8.12%4.59%5.67%10.75%8.10%
EPS
3.943.913.267.643.725.706.28
EPS Growth
57.38%-0.76%-16.62%134.36%-51.31%53.29%10.19%
Forward PE
-----16.4614.94
No. Analysts -----3231
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2026202720282029203020312032
High 53.3B 58.5B
Avg 49.1B 53.1B
Low 46.4B 49.7B

Revenue Growth

Revenue Growth 2026202720282029203020312032
High
20.2%
19.1%
Avg
10.7%
8.1%
Low
4.6%
1.3%

EPS Forecast

EPS 2026202720282029203020312032
High 6.06 6.70
Avg 5.70 6.28
Low 5.33 5.94

EPS Growth

EPS Growth 2026202720282029203020312032
High
62.9%
17.5%
Avg
53.3%
10.2%
Low
43.3%
4.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.